Melissa K. Carpenter
Direktor/Vorstandsmitglied bei The International Society for Stem Cell Research
Profil
Dr. Melissa K.
Carpenter is an Associate at Proteus Venture Partners LLC (Venture Capital).
Dr. Carpenter was previously employed as Vice President-Research & Development by ViaCyte, Inc. She was also employed at CytoTherapuetics, Inc. and served on the board at Geron Corp.
and CyThera, Inc.
Dr. Carpenter received her PhD in Laboratory of Cellular and Molecular Neurobiology from the University of California, Irvine.
Aktive Positionen von Melissa K. Carpenter
| Unternehmen | Position | Beginn |
|---|---|---|
| The International Society for Stem Cell Research | Direktor/Vorstandsmitglied | 18.03.2021 |
Ehemalige bekannte Positionen von Melissa K. Carpenter
| Unternehmen | Position | Ende |
|---|---|---|
Proteus RM LLC (Venture Capital)
 Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Private Equity Investor | - |
| CytoTherapuetics, Inc. | Corporate Officer/Principal | - |
CyThera, Inc.
 CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| GERON CORPORATION | Corporate Officer/Principal | - |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Melissa K. Carpenter
| University of California, Irvine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GERON CORPORATION | Health Technology |
| Private Unternehmen | 5 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
CyThera, Inc.
CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Commercial Services |
| CytoTherapuetics, Inc. | Finance |
| The International Society for Stem Cell Research | |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Finance |
